Skip to content
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
Profitability
Gross margin48.8%+15.1pp46.4%+21.7pp43.5%+30.2pp40.5%+39.2pp33.6%
Operating margin-171.5%-11.2pp-174.3%+19.2pp-175.9%+68.5pp-177.8%+128pp-160.4%
Net margin-173%-0.8pp-178%+32.9pp-180.3%+88.6pp-190.3%+148pp-172.2%
EBITDA margin-161.7%-19.6pp-163.4%+5.9pp-164.5%+47.1pp-164.5%+99.7pp-142.1%
Free cash flow margin-142.9%+39.2pp-152.9%+62.7pp-166.3%+94.9pp-168.1%+136pp-182.1%
Liquidity
Current ratio7.3×5.5×6.8×6.7×+6.3×
Quick ratio7.3×5.5×6.8×6.7×+6.3×
Cash ratio6.8×4.9×6.2×6.3×+6.0×
Leverage
Debt-to-assets0.1×0.2×0.2×0.1×-0.8×
Interest coverage-19.2×-8.7×-17.6×-6.6×-15×-2.5×-13.8×-0.1×-10.5×
Valuation
Market capitalization$1.32B+70.8%$1.41B$847.25M
Enterprise value$1.07B$1.28B$690.63M
Price / sales15.7×19×12.8×
EV / sales12.8×17.2×10.4×
Free cash flow yield-9.1%-8.1%-13%
Earnings yield-11%-9.4%-14.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) runs a 48.8% gross margin and a -171.5% operating margin, with a -173.0% net margin.
Where do Kestra Medical Technologies, Ltd. Common Stock's ratios come from?
Every ratio is computed from Kestra Medical Technologies, Ltd. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.